Patents by Inventor Martin Wienisch

Martin Wienisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11643670
    Abstract: Described herein are methods of enhancing chromosomal homologous recombination to stimulate a loss of heterozygosity at a gene locus of interest in a living cell. These methods are driven by an enhancer component and a target-specific endonuclease component and proceed through a mechanism whereby: exogenous donor DNA that is homologous to the gene locus of interest is not introduced into the living cell; the desired allele of the gene locus of interest remains uncleaved; and the undesired allele is either uncleaved, cleaved at a single location, or cleaved at multiple locations. These methods have numerous applications, including the repair of risk alleles for disease prevention, the correction of heterozygous mutations in dividing cells, the design of cancer therapeutics, and the design of novel gene-drive strategies.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 9, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: Guoping Feng, Jonathan Wilde, Tomomi Aida, Martin Wienisch, Qiangge Zhang
  • Publication number: 20190233846
    Abstract: Described herein are methods of enhancing chromosomal homologous recombination to stimulate a loss of heterozygosity at a gene locus of interest in a living cell. These methods are driven by an enhancer component and a target-specific endonuclease component and proceed through a mechanism whereby: exogenous donor DNA that is homologous to the gene locus of interest is not introduced into the living cell; the desired allele of the gene locus of interest remains uncleaved; and the undesired allele is either uncleaved, cleaved at a single location, or cleaved at multiple locations. These methods have numerous applications, including the repair of risk alleles for disease prevention, the correction of heterozygous mutations in dividing cells, the design of cancer therapeutics, and the design of novel gene-drive strategies.
    Type: Application
    Filed: January 29, 2019
    Publication date: August 1, 2019
    Applicant: Massachusetts Institute of Technology
    Inventors: Guoping Feng, Jonathan Wilde, Tomomi Aida, Martin Wienisch, Qiangge Zhang